Cerus | CERS - Gross Profit On Sales

Stock Price
2.05
Daily Change
-0.20 -8.71%
Monthly
-7.05%
Yearly
33.66%
Q1 Forecast
2.48

Cerus reported $33.33M in Gross Profit on Sales for its fiscal quarter ending in December of 2024.





Gross Profit On Sales Change Date
Cerus USD 33.33M 8.66M Dec/2024
GRIFOLS EUR 743.8M 49.13M Jun/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Neogen USD 94.97M 2.11M Jun/2025
OraSure Technologies USD 17.07M 7.62M Sep/2024
Quidel USD 274.8M 1.01B Dec/2025
Rockwell Medical USD 4.55M 1.49M Jun/2024
STAAR Surgical USD 43.74M 34.13M Dec/2025
Terumo JPY 153.19B 6.2B Dec/2025
Utah Medical Products USD 5.8M 450K Sep/2024